Tumour-selective activity of RAS-GTP inhibition in pancreatic cancer
2024 · Nature · 157 citations
https://doi.org/10.1038/s41586-024-07379-z
M
Marie C. Hasselluhn
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
336
Citations
9
h-index
9
i10-index
Marie C. Hasselluhn is an academic researcher from Columbia University Irving Medical Center. The author has contributed to research in topics: Circular RNAs in diseases & MicroRNA in disease regulation & Pancreatic and Hepatic Oncology Research. The author has an h-index of 9, co-authored 84 publications.
ORCID: 0000-0001-9765-4075Papers by this author
worksAberrant NFATc1 signaling counteracts TGFβ-mediated growth arrest and apoptosis induction in pancreatic cancer progression
2019 · Cell Death and Disease · 16 citations
https://doi.org/10.1038/s41419-019-1682-2
Supplementary Figure 1 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25191599.v1
Supplementary Tables 1 - 4 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25191554.v1
Supplementary Figure 6 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25191581
Supplementary Figure 5 from Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression
2024 · 0 citations
https://doi.org/10.1158/2159-8290.25191587.v1
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat